CN1931301A - 一种治疗乳腺增生的中药制剂及其制备方法 - Google Patents
一种治疗乳腺增生的中药制剂及其制备方法 Download PDFInfo
- Publication number
- CN1931301A CN1931301A CNA2006101525958A CN200610152595A CN1931301A CN 1931301 A CN1931301 A CN 1931301A CN A2006101525958 A CNA2006101525958 A CN A2006101525958A CN 200610152595 A CN200610152595 A CN 200610152595A CN 1931301 A CN1931301 A CN 1931301A
- Authority
- CN
- China
- Prior art keywords
- radix
- chinese medicine
- hour
- reduced pressure
- under reduced
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 124
- 238000000034 method Methods 0.000 title claims description 9
- 238000002360 preparation method Methods 0.000 claims abstract description 27
- 239000000463 material Substances 0.000 claims abstract description 7
- 210000000582 semen Anatomy 0.000 claims description 51
- 239000000706 filtrate Substances 0.000 claims description 41
- 229940079593 drug Drugs 0.000 claims description 39
- 239000000843 powder Substances 0.000 claims description 34
- 239000000047 product Substances 0.000 claims description 34
- 238000010438 heat treatment Methods 0.000 claims description 27
- 241000628997 Flos Species 0.000 claims description 25
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 25
- 238000001035 drying Methods 0.000 claims description 25
- 238000007689 inspection Methods 0.000 claims description 25
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 25
- 238000012856 packing Methods 0.000 claims description 23
- 239000006071 cream Substances 0.000 claims description 21
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 20
- 230000006837 decompression Effects 0.000 claims description 20
- 238000000605 extraction Methods 0.000 claims description 20
- 238000001914 filtration Methods 0.000 claims description 20
- 238000004321 preservation Methods 0.000 claims description 20
- 238000010992 reflux Methods 0.000 claims description 20
- 239000000203 mixture Substances 0.000 claims description 17
- 239000009636 Huang Qi Substances 0.000 claims description 16
- 239000008187 granular material Substances 0.000 claims description 16
- 241001250596 Pleione Species 0.000 claims description 15
- 239000006187 pill Substances 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- 238000002386 leaching Methods 0.000 claims description 13
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 11
- 229920003123 carboxymethyl cellulose sodium Polymers 0.000 claims description 11
- 229940063834 carboxymethylcellulose sodium Drugs 0.000 claims description 11
- 238000002156 mixing Methods 0.000 claims description 10
- 235000012907 honey Nutrition 0.000 claims description 9
- 239000012141 concentrate Substances 0.000 claims description 8
- 230000001954 sterilising effect Effects 0.000 claims description 7
- 238000004659 sterilization and disinfection Methods 0.000 claims description 7
- 238000007796 conventional method Methods 0.000 claims description 6
- 230000000694 effects Effects 0.000 abstract description 22
- 230000017531 blood circulation Effects 0.000 abstract description 10
- 230000001737 promoting effect Effects 0.000 abstract description 9
- 208000004396 mastitis Diseases 0.000 abstract description 6
- 210000004185 liver Anatomy 0.000 abstract description 4
- 230000001154 acute effect Effects 0.000 abstract description 3
- 238000005516 engineering process Methods 0.000 abstract description 3
- 206010061218 Inflammation Diseases 0.000 abstract description 2
- 230000004054 inflammatory process Effects 0.000 abstract description 2
- 241000202726 Bupleurum Species 0.000 abstract 1
- 241000234653 Cyperus Species 0.000 abstract 1
- 235000002848 Cyperus flabelliformis Nutrition 0.000 abstract 1
- 244000236658 Paeonia lactiflora Species 0.000 abstract 1
- 235000008598 Paeonia lactiflora Nutrition 0.000 abstract 1
- 244000248825 Peltandra virginica Species 0.000 abstract 1
- 235000001188 Peltandra virginica Nutrition 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 208000007536 Thrombosis Diseases 0.000 abstract 1
- 230000003467 diminishing effect Effects 0.000 abstract 1
- 210000000481 breast Anatomy 0.000 description 27
- 208000002193 Pain Diseases 0.000 description 16
- 230000036407 pain Effects 0.000 description 16
- 238000003745 diagnosis Methods 0.000 description 11
- 230000002146 bilateral effect Effects 0.000 description 10
- 208000024891 symptom Diseases 0.000 description 10
- 239000008280 blood Substances 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 8
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 8
- 238000001694 spray drying Methods 0.000 description 8
- 206010020880 Hypertrophy Diseases 0.000 description 6
- 238000002604 ultrasonography Methods 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 5
- 239000002671 adjuvant Substances 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 239000004375 Dextrin Substances 0.000 description 4
- 229920001353 Dextrin Polymers 0.000 description 4
- 229920002472 Starch Polymers 0.000 description 4
- 239000002775 capsule Substances 0.000 description 4
- 235000019425 dextrin Nutrition 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 230000003203 everyday effect Effects 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 235000019359 magnesium stearate Nutrition 0.000 description 4
- 210000005075 mammary gland Anatomy 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 239000000741 silica gel Substances 0.000 description 4
- 229910002027 silica gel Inorganic materials 0.000 description 4
- 239000008107 starch Substances 0.000 description 4
- 235000019698 starch Nutrition 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 206010020718 hyperplasia Diseases 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 206010006187 Breast cancer Diseases 0.000 description 2
- 208000026310 Breast neoplasm Diseases 0.000 description 2
- 206010006298 Breast pain Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 208000006662 Mastodynia Diseases 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 201000008275 breast carcinoma Diseases 0.000 description 2
- 208000037976 chronic inflammation Diseases 0.000 description 2
- 230000006020 chronic inflammation Effects 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 230000000994 depressogenic effect Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 206010025482 malaise Diseases 0.000 description 2
- 230000002175 menstrual effect Effects 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 239000000583 progesterone congener Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- GCKMFJBGXUYNAG-UHFFFAOYSA-N 17alpha-methyltestosterone Natural products C1CC2=CC(=O)CCC2(C)C2C1C1CCC(C)(O)C1(C)CC2 GCKMFJBGXUYNAG-UHFFFAOYSA-N 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 206010070840 Gastrointestinal tract irritation Diseases 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- GCKMFJBGXUYNAG-HLXURNFRSA-N Methyltestosterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@](C)(O)[C@@]1(C)CC2 GCKMFJBGXUYNAG-HLXURNFRSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- -1 and light Substances 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 235000019636 bitter flavor Nutrition 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000006196 drop Substances 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 201000010759 hypertrophy of breast Diseases 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000003978 infusion fluid Substances 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 229960001566 methyltestosterone Drugs 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 210000002445 nipple Anatomy 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 210000004681 ovum Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229940098465 tincture Drugs 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006101525958A CN100506251C (zh) | 2006-09-29 | 2006-09-29 | 一种治疗乳腺增生的中药制剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006101525958A CN100506251C (zh) | 2006-09-29 | 2006-09-29 | 一种治疗乳腺增生的中药制剂及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1931301A true CN1931301A (zh) | 2007-03-21 |
CN100506251C CN100506251C (zh) | 2009-07-01 |
Family
ID=37877426
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2006101525958A Expired - Fee Related CN100506251C (zh) | 2006-09-29 | 2006-09-29 | 一种治疗乳腺增生的中药制剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100506251C (zh) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101129527B (zh) * | 2007-08-23 | 2010-05-19 | 王培凤 | 治疗乳腺疾病的药物 |
CN102370948A (zh) * | 2011-11-17 | 2012-03-14 | 中国中医科学院中医临床基础医学研究所 | 一种治疗乳腺增生的中药复方制剂及其制备方法 |
CN102552765A (zh) * | 2012-01-17 | 2012-07-11 | 张敏 | 一种治疗乳腺增生的药剂 |
CN103157055A (zh) * | 2013-03-18 | 2013-06-19 | 赵辉 | 一种治疗乳腺增生的中药制剂 |
CN103263558A (zh) * | 2013-06-07 | 2013-08-28 | 天津百若克医药生物技术有限责任公司 | 一种治疗乳腺增生的中药组合物及制备方法 |
CN103656067A (zh) * | 2013-11-29 | 2014-03-26 | 周晨 | 一种治疗乳腺增生的中药配方 |
CN103877431A (zh) * | 2014-04-22 | 2014-06-25 | 杨明 | 一种治疗慢性乳腺炎的药物组合物 |
CN103623339B (zh) * | 2013-08-09 | 2014-10-08 | 马建 | 一种外用治疗乳腺增生的药物及其制备方法 |
CN105616990A (zh) * | 2016-01-27 | 2016-06-01 | 青岛云天生物技术有限公司 | 一种治疗乳腺增生的药物制剂 |
CN106075027A (zh) * | 2016-07-19 | 2016-11-09 | 辽宁中医药大学 | 一种治疗乳腺增生的中药组合物 |
CN106620550A (zh) * | 2017-03-23 | 2017-05-10 | 李晶晶 | 治疗乳腺增生的药物及其制备方法 |
-
2006
- 2006-09-29 CN CNB2006101525958A patent/CN100506251C/zh not_active Expired - Fee Related
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101129527B (zh) * | 2007-08-23 | 2010-05-19 | 王培凤 | 治疗乳腺疾病的药物 |
CN102370948A (zh) * | 2011-11-17 | 2012-03-14 | 中国中医科学院中医临床基础医学研究所 | 一种治疗乳腺增生的中药复方制剂及其制备方法 |
CN102552765A (zh) * | 2012-01-17 | 2012-07-11 | 张敏 | 一种治疗乳腺增生的药剂 |
CN102552765B (zh) * | 2012-01-17 | 2013-06-12 | 张敏 | 一种治疗乳腺增生的药剂 |
CN103157055B (zh) * | 2013-03-18 | 2014-06-11 | 赵辉 | 一种治疗乳腺增生的中药制剂 |
CN103157055A (zh) * | 2013-03-18 | 2013-06-19 | 赵辉 | 一种治疗乳腺增生的中药制剂 |
CN103263558A (zh) * | 2013-06-07 | 2013-08-28 | 天津百若克医药生物技术有限责任公司 | 一种治疗乳腺增生的中药组合物及制备方法 |
CN103623339B (zh) * | 2013-08-09 | 2014-10-08 | 马建 | 一种外用治疗乳腺增生的药物及其制备方法 |
CN103656067A (zh) * | 2013-11-29 | 2014-03-26 | 周晨 | 一种治疗乳腺增生的中药配方 |
CN103877431A (zh) * | 2014-04-22 | 2014-06-25 | 杨明 | 一种治疗慢性乳腺炎的药物组合物 |
CN103877431B (zh) * | 2014-04-22 | 2016-03-23 | 杨明 | 一种治疗慢性乳腺炎的药物组合物 |
CN105616990A (zh) * | 2016-01-27 | 2016-06-01 | 青岛云天生物技术有限公司 | 一种治疗乳腺增生的药物制剂 |
CN106075027A (zh) * | 2016-07-19 | 2016-11-09 | 辽宁中医药大学 | 一种治疗乳腺增生的中药组合物 |
CN106075027B (zh) * | 2016-07-19 | 2019-10-11 | 辽宁中医药大学 | 一种治疗乳腺增生的中药组合物 |
CN106620550A (zh) * | 2017-03-23 | 2017-05-10 | 李晶晶 | 治疗乳腺增生的药物及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN100506251C (zh) | 2009-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100506251C (zh) | 一种治疗乳腺增生的中药制剂及其制备方法 | |
CN1061854C (zh) | 治疗、预防妇科疾患的药物制剂 | |
CN101028507A (zh) | 一种治疗哮喘病的中药组合物 | |
CN1312098A (zh) | 一种治疗风湿、类风湿等痹症的药酒 | |
CN1310654C (zh) | 一种治疗妇科疾病的药物及其制备方法 | |
CN1167454C (zh) | 一种通过神阙穴进行排毒的中药组合物及其制备方法 | |
CN1824205B (zh) | 治疗慢性前列腺炎的药物及其制备方法 | |
CN1686511A (zh) | 具有疏肝健脾、养血调经丹栀逍遥的药物及其制备方法 | |
CN1686506A (zh) | 一种治疗乳腺增生疾病的药物和制备方法及其应用 | |
CN1686296A (zh) | 一种治疗疼痛的药物组合物及其制备方法和应用 | |
CN102755515B (zh) | 治疗乳腺增生的中药汤剂 | |
CN109248305A (zh) | 一种治疗肝纤维化的中药组合物及其制备方法 | |
CN1709288A (zh) | 一种药物组合物及其制备方法和用途 | |
CN1237443A (zh) | 一种治疗风湿性心脏病的药物 | |
CN1285354C (zh) | 一种治疗脑梗塞的药物 | |
CN1318378A (zh) | 治疗热症的中成药 | |
CN1303689A (zh) | 一种治疗妇科病的药 | |
CN1094057C (zh) | 一种治疗肝腹水的药物 | |
CN1260973A (zh) | 保健茶枕 | |
CN1927282A (zh) | 用于治疗关节炎的制剂及其制备方法 | |
CN103191369A (zh) | 一种治疗乳腺增生的中药组合物 | |
CN1544019A (zh) | 一种治疗痹证型颈椎病的中药复方制剂及制备方法 | |
CN101912547B (zh) | 一种治疗眩晕的药物及其制备方法 | |
CN101259250A (zh) | 一种活血化瘀、软坚散结的药物组合及其制备方法 | |
CN1733197A (zh) | 一种治疗慢性前列腺炎的药物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
C41 | Transfer of patent application or patent right or utility model | ||
PB01 | Publication | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20070126 Address after: Wanquan Beijing Road, Haidian District No. 68 Zijin estate building No. 7 1712 Applicant after: Tianjin Bainuoke Medicine Biotechnology Co., Ltd. Address before: Wanquan Beijing Road, Haidian District No. 68 Zijin estate building No. 7 1712 Applicant before: Mao Zhizhong |
|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
DD01 | Delivery of document by public notice |
Addressee: The Intellectual Property Department of Tianjin bairuoke biotechnology limited liability company responsible person Document name: Notification to Pay the Fees |
|
DD01 | Delivery of document by public notice |
Addressee: Tang Hewen Document name: Notification of Termination of Patent Right |
|
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20090701 Termination date: 20100929 |